Skip to main content
OpenTrials
Completed

NCT Number: NCT05044624

Retroperıtoneal Soft-Tıssue Sarcomas

: Soft Tissue Sarcomas are rare mesenchymal tumors with many subtypes. Clean margin-wide resection is recommended for treatment. The guidelines recommend that sarcoma treatments be carried out in sarcoma centers. In this study, the location, histopathological features, clinical and demographic features, recurrence, and prognosis of retroperitoneal sarcomas were investigated.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Retroperitoneal Sarcoma Margin, Tumor-Free Margins of Excision Morphological and Microscopic Findings Neoplasms Neoplasms by Histologic Type Neoplasms, Connective and Soft Tissue Pathological Conditions, Signs and Symptoms Sarcoma

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

The demographic, histopathological, and immunohistochemical data of the patients who were operated on with the diagnosis of intraabdominal mass at Istanbul Medeniyet University Göztepe Prof. Dr. Süleyman Yalçın City Hospital from March 2016 to December 2020 were retrospectively evaluated. Ethical approval was obtained from Istanbul Medeniyet University Göztepe Prof. Dr. Süleyman Yalçın City Hospital Ethics Committee.

Patients diagnosed with pathological sarcoma subclass were included in the study. Patients younger than 18 years were excluded from the study. Visceral organ-origin sarcomas and extremity sarcomas were also excluded from the study. GIST's were included in sarcoma subtypes by WHO in 2013. However, they were not included in the study due to their solid organ origin.

The data of 18 patients' whore remained after the exclusion criteria were analyzed retrospectively. Pathology samples of the patients were re-examined by a single pathologist.

The demographic analysis was used for statistics.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients operated with the diagnosis of intra-abdominal mass
  • patients diagnosed with pathological sarcoma subclasses

Exclusion criteria

  • Patients younger than 18 years
  • Visceral organ-origin sarcomas
  • extremity sarcomas
  • GIST

Treatment and study plan

retroperitoneal mass excision

Procedure

retroperitoneal mass excision

Primary outcomes

  1. Clean margin wide resection

    Time frame: 63 month

    effect of clean surgical margin on recurrence

Sponsors and collaborators

Lead sponsor

Istanbul Medeniyet University

Other

Registry information

Official study title

Retroperıtoneal Soft-Tıssue Sarcomas: Retrospectıve Clınıcal Study

Important dates

Study start
2016
Primary completion
2021
Study completion
2021
First posted
Sep 16, 2021
Registry last updated
Sep 16, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.